PRIMARY CNS LYMPHOMA (PCNSL)
Clinical trials for PRIMARY CNS LYMPHOMA (PCNSL) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CNS LYMPHOMA (PCNSL) trials appear
Sign up with your email to follow new studies for PRIMARY CNS LYMPHOMA (PCNSL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough brain cancer: trial tests powerful Immune-Boosting combo
Disease control Recruiting nowThis study is testing a new three-drug combination for people with an aggressive type of brain lymphoma that has come back or stopped responding to prior treatment. The goal is to see if adding a new immune-boosting drug called epcoritamab to two existing drugs can better control…
Matched conditions: PRIMARY CNS LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Engineered immune cells target aggressive brain cancer in new trial
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for adults with a hard-to-treat lymphoma that affects the brain and spinal cord. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back into the p…
Matched conditions: PRIMARY CNS LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: Hyungwoo Cho • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC